AlphaYouRVMD: Sandler Alan B. discloses a sale
By AlphaYouPublished Form 4
Sandler Alan B.
Reporting filer
Sandler Alan B. reported Sale in Revolution Medicines, Inc.: 5 units of Common Stock, dated 2026-09-16. The full Form 4 contains 2 transaction entries.
- Disclosed
- Sep 18, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Sandler Alan B. | 2026-09-16 | S | Sale | 5 | 194.9589 | 53,204 | 2 days | Filed terms
|
| Common Stock | Sandler Alan B. | 2026-09-16 | S | Sale | 336 | 199.3032 | 52,868 | 2 days | Filed terms
|
Common Stock
- Owner
- Sandler Alan B.
- Date
- 2026-09-16
- Code
- S
- Action
- Sale
- Quantity
- 5
- Price
- 194.9589
- Following holdings
- 53,204
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-16
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 5
- transaction Price Per Share: 194.9589
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 53204
- id: F2
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Sandler Alan B.
- Date
- 2026-09-16
- Code
- S
- Action
- Sale
- Quantity
- 336
- Price
- 199.3032
- Following holdings
- 52,868
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-16
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 336
- transaction Price Per Share: 199.3032
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 52868
- id: F3
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Sandler Alan B.: Chief Development Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on June 13, 2026 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units.
- F2: Includes 209 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026.
- F3: Includes 52,350 restricted stock units.
Original sources
Prepared automatically from public filing data. Report a correction.